Lifeward (LFWD) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -16.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.50% |
| Dec 31, 2025 | -21.63% |
| Sep 30, 2025 | -18.38% |
| Jun 30, 2025 | 1.70% |
| Mar 31, 2025 | 12.87% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 7.88% |
| Jun 30, 2024 | 23.42% |
| Mar 31, 2024 | 31.38% |
| Dec 31, 2023 | 22.08% |
| Sep 30, 2023 | 12.80% |
| Jun 30, 2023 | 41.18% |
| Mar 31, 2023 | 15.17% |
| Dec 31, 2022 | 13.23% |
| Sep 30, 2022 | 10.68% |
| Jun 30, 2022 | -18.02% |
| Mar 31, 2022 | -21.72% |
| Dec 31, 2021 | -17.97% |
| Sep 30, 2021 | -23.84% |
| Jun 30, 2021 | -41.96% |
| Mar 31, 2021 | -40.46% |
| Dec 31, 2020 | -42.12% |
| Sep 30, 2020 | -36.33% |
| Jun 30, 2020 | -48.90% |
| Mar 31, 2020 | -38.39% |
| Dec 31, 2019 | -36.65% |
| Sep 30, 2019 | -36.35% |
| Jun 30, 2019 | -27.56% |
| Mar 31, 2019 | -23.66% |
| Dec 31, 2018 | -13.76% |
| Sep 30, 2018 | 0.65% |
| Jun 30, 2018 | 20.48% |
| Mar 31, 2018 | 10.75% |
| Dec 31, 2017 | 54.07% |
| Dec 31, 2016 | 134.39% |